The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Jun. 07, 2018
Applicant:
Venatorx Pharmaceuticals, Inc., Malvern, PA (US);
Inventors:
Christopher J. Burns, Malvern, PA (US);
Daniel C. Pevear, Downingtown, PA (US);
Robert E. Lee Trout, Collegeville, PA (US);
Randy W. Jackson, Livingston, MT (US);
Jodie Hamrick, New Holland, PA (US);
Allison L. Zulli, Chesterbrook, PA (US);
Eugen F. Mesaros, Wallingford, PA (US);
Steven A. Boyd, Chester Springs, PA (US);
Assignee:
VENATORX PHARMACEUTICALS, INC., Malvern, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 5/02 (2006.01); A61K 31/69 (2006.01); A61P 31/04 (2006.01); A61K 45/06 (2006.01); A61K 31/427 (2006.01); A61K 31/43 (2006.01); A61K 31/545 (2006.01); A61K 31/546 (2006.01);
U.S. Cl.
CPC ...
C07F 5/025 (2013.01); A61K 31/427 (2013.01); A61K 31/43 (2013.01); A61K 31/545 (2013.01); A61K 31/546 (2013.01); A61K 31/69 (2013.01); A61K 45/06 (2013.01); A61P 31/04 (2018.01); A61K 2300/00 (2013.01);
Abstract
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.